Home › Funds › D. E. Shaw & Co › PCVX
D. E. Shaw & Co position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)1.90M sh
Reported value held$110.56M
Portfolio Weight0.06%
First reportedQ4 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 972.32K | $46.62M | New |
| Q1 2023 | 794.91K | $29.79M | Reduce |
| Q2 2023 | 812.91K | $40.60M | Add |
| Q3 2023 | 538.38K | $27.45M | Reduce |
| Q4 2023 | 438.31K | $27.53M | Reduce |
| Q1 2024 | 367.25K | $25.09M | Reduce |
| Q2 2024 | 230.21K | $17.38M | Reduce |
| Q3 2024 | 423.50K | $48.39M | Add |
| Q4 2024 | 775.65K | $63.49M | Add |
| Q1 2025 | 867.89K | $32.77M | Add |
| Q2 2025 | 3.09M | $100.41M | Add |
| Q3 2025 | 4.29M | $154.55M | Add |
| Q4 2025 | 3.63M | $167.54M | Reduce |
| Q1 2026 | 2.87M | $166.50M | Reduce |
| Q2 2026 | 1.90M | $110.56M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026